Optimizing the relationship between infection prevention and antimicrobial stewardship.
Expansion of antimicrobial stewardship strategies to include vertical methods represents an opportunity for programs, both new and established, to further optimize antimicrobial use.
In this narrative review of studies evaluating antiretroviral stewardship programs (ARVSPs), we propose core elements for ARVSPs that are based on published evidence, clinical experience, and adapted from antimicrobial stewardship programs.
Shorter durations of antibiotic therapy demonstrate similar efficacy and may improve safety compared with longer courses for certain infections.
A new study confirms the ribavirin steady-state serum levels that correspond to high rates of efficacy and low adverse events.
Novel modes of delivery are imperative to improve HIV suppression and prevent transmission.
Candida auris—Are we prepared for another multidrug-resistant pathogen?
The CDC, WHO, and other global entities are working together to understand and control this novel coronavirus and provide important guidelines for health care professionals. Here’s what you should know.
Both the United Nations and World Health Organization (WHO) discussed the threat of H5N1, and its potential transmission to other mammals and humans.
Children in the United States will be able to avoid potentially millions of hours of at-home quarantining under a testing program unveiled by the CDC today.
SMUCLA implements high-touch wipe down intervention to address the need for environmental disinfection of cancer patient care areas.
“A bite bug in the belly.”
Recent research shows no clinical benefits from adding azithromycin to standard treatment for adults who presented to emergency departments with acute asthma exacerbations requiring a corticosteroid course.
New public health perspectives on aspergillosis, sporotrichosis, histoplasmosis, and coccidioidomycosis.
Fecal microbiota transplantation (FMT) is a widely accepted, safe, and effective treatment for recurrent Clostridium diffi­cile infection (rCDI), but does the cure endure?
The virulent pathogen has significant individual and public health implications.
The pharmaceutical industry plays an essential role in advancing antimicrobial stewardship and addressing the growing threat of resistant pathogens.
This training will empower pharmacists practicing in LTC facilities to develop antimicrobial stewardship programs, improve patient outcomes related to infectious diseases, and facilitate compliance with CMS requirements.
A new agent in the antibiotic pipeline, cefiderocol, has proved to be effective against complicated urinary tract infections (UTIs).
An epidemiologist explores the changing epidemiology of a familiar disease.
Review authors discuss current knowledge regarding psychobiotics and identify questions for future research.
Evidence suggests AUC-guided vancomycin dosing is a safer method than traditional trough-guided dosing.
Although Cuba reported no cases of Zika virus in 2017 and 2018, investigators used travel data and genomic epidemiology to uncover a large, “hidden” Zika outbreak.
As the leading cause of unplanned 30-day hospital readmissions, sepsis affects more than 1.5 million individuals each year.
Epidemiologic and clinical lessons for the uninitiated.
Several recent studies provide valuable insight surrounding the appropriateness of transitioning from intravenous to oral therapy when treating bacteremic urinary tract infections.
Adriano de Bernardi Schneider, MS, PhD Candidate, Contagion® Editorial Advisory Board Member, provides a brief snapshot into some of his work on mapping the evolution of the Zika virus.